Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Progression in End-Stage Kidney Disease

NCT04495907 is registered in ClinicalTrials.gov with Davita Clinical Research as lead sponsor.

NCT NCT04495907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04495907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Progression in End-Stage Kidney Disease
Lead sponsor
Davita Clinical Research
Phase
Observational
Overall status
Completed
Start date
August 6, 2020
Completion date
August 31, 2021
Enrollment
412 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection (asymptomatic), sars-cov-2 infection (symptomatic)